Reporter July 10 2015

Drug signaling networks

Vanderbilt investigators have developed a new algorithm to understand the networks of signaling molecules that control drug action.

Hhex on cancer

A new mouse model demonstrates that the Hhex gene – which is linked to blood cancers – is critical for normal blood cell production.

Delivering cells for heart repair

A polymer hydrogel material developed by Vanderbilt scientists improved the delivery of stem cells for heart repair.

Signals of schizophrenia

Vanderbilt researchers have discovered a possible molecular mechanism of schizophrenia that could lead to new treatments for the disorder.

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

Gates grant bolsters study of Tdap boosters in pregnant women

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.

1 2